Target intelligence / Profile preview

TBC1 domain family member 7 (TBC1D7)

Target
TBC1D7
Molecular classification
Other (TBC-domain containing protein; subunit of multiprotein complex), Regulatory protein (complex support protein in cellular growth pathways)
01

Overview

TBC1 domain family member 7 (TBC1D7) is a protein that serves as the third core subunit of the tuberous sclerosis complex (TSC), binding to TSC1 and stabilizing the TSC1-TSC2 complex, which is a major negative regulator of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway controlling cell growth, autophagy, and differentiation. Unlike other TBC-domain proteins, TBC1D7 lacks critical Rab-GAP catalytic motifs and thus is not a classical GTPase-activating protein, though weak activity toward Rab17 has been described in vitro. Pathologically, biallelic mutations in TBC1D7 are associated with neurodevelopmental disorders including intellectual disability and megalencephaly, while increased expression has been linked to susceptibility in certain cancers and migraine. TBC1D7 is not a therapeutic target in the classical sense (e.g., receptor, enzyme, transporter) and no approved or experimental drugs are known to directly target it.

Other names
TBC7HSPC239dJ257A7.3FLJ32666Cell migration-inducing protein 23TS complex subunit 3Tre2-Bub2-Cdc16 domain family member 7MGCPHPIG51TBC1D7-LOC100130357
02

Biological functions

Regulation of mTORC1 signaling pathwayNegative regulation of cell growth (via TSC1-TSC2 complex)Regulation of autophagyPossible GTPase activator activity (weak/inconclusive evidence for GAP activity)Regulation of cell differentiation
03

Disease associations

Megalencephaly (macrocephaly)Intellectual disabilityLung cancer (elevated expression linked as possible biomarker/role)Migraine susceptibility locusCeliac disease (in rare genetic loss-of-function cases)
04

Safety considerations

Homozygous inactivation leads to intellectual disability and megalencephalyPotential developmental implications linked to mTOR pathway imbalance
05

Biomarkers

Increased TBC1D7 expression correlates with lung cancer

Beyond the preview

Go deeper on TBC1 domain family member 7 (TBC1D7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 7 (TBC1D7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call